News

Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study ...
Abstract: The research program for an eventual neutrino factory or muon collider needs a magnet of /spl sim/0.15 m diameter bore to generate /spl sim/20 T over a length of /spl sim/0.3 m. Downstream ...
Issued 1 May 2025 — Monthly Summary for Australia — Product Code IDCKGC1AR0 ...